Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data

EJNMMI Research

Volumn 7, Issue , 2017, Pages

  Matheson, Granville J ^a   Plavén Sigray, Pontus ^a   Forsberg, Anton ^a   Varrone, Andrea ^a   Farde, Lars ^a,b   Cervenka, Simon ^a,c  

^a STOCKHOLM COUNTY COUNCIL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

DVR; PET; SUVR; TSPO; 11C PBR28

Indexed keywords

CARBON 11; RADIOLIGAND;

ADULT; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONSTANTS AND COEFFICIENTS; DORSAL STRIATUM; FEMALE; FRONTAL CORTEX; HUMAN; MALE; MATHEMATICAL MODEL; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RELIABILITY; STANDARDISED UPTAKE VALUE; TEMPORAL CORTEX; THALAMUS; VOLUME OF DISTRIBUTION RATIO; YOUNG ADULT;

EID: 85025479065     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/s13550-017-0304-1     Document Type: Article

References (13)

1. Doble A, Malgouris C, Daniel M, et al. Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H] PK 11195: anatomical and subcellular distribution. Brain Res Bull. 1987;18(1):49–61.
2. Collste K, Forsberg A, Varrone A, Amini N, Aeinehband S, Yakushev I, et al. Test–retest reproducibility of [11C]PBR28 binding to TSPO in healthy control subjects. Eur J Nucl Med Mol Imaging. 2016;43:173–83.
3. Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metabo SAGE Publ. 2012;32:1–5.
4. Lyoo CH, Ikawa M, Liow J-S, Zoghbi SS, Morse CL, Pike VW, et al. Cerebellum can serve as a pseudo-reference region in Alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein. Journal of nuclear medicine. Soc Nuclear Med. 2015;56:701–6.
5. Bloomfield PS, Selvaraj S, Veronese M, Rizzo G, Bertoldo A, Owen DR, et al. Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [11C] PBR28 PET brain imaging study. American Journal of Psychiatry. Am Psychiatric Assoc. 2015;173(1):44–52.
6. Loggia ML, Chonde DB, Akeju O, Arabasz G, Catana C, Edwards RR, et al. Evidence for brain glial activation in chronic pain patients. Brain Oxford Univ Press. 2015;138:604–15.
7. Nair A, Veronese M, Xu X, Curtis C, Turkheimer F, Howard R, et al. Test-retest analysis of a non-invasive method of quantifying [11C]-PBR28 binding in Alzheimer’s disease. EJNMMI research Springer. 2016;6:72.
8. Collste K, Plavén-Sigray P, Fatouros-Bergman H, Victorsson P, Schain M, Forsberg A, et al. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C] PBR28. Molecular Psychiatry. Nature Publishing Group. 2017;22(6):850–56.
9. Weir JP. Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res LWW. 2005;19:231–40.
10. Kreisl WC, Mbeo G, Fujita M, Zoghbi SS, Pike VW, Innis RB, et al. Stroke incidentally identified using improved positron emission tomography for microglial activation. Arch Neurol Am Med Assoc. 2009;66:1288–9.
11. Lakens D. Equivalence Tests. Social Psychological and Personality Science; 2017;8(4):355–62.
12. Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987;15:657–80.
13. Yoder KK, Territo PR, Hutchins GD, et al. Comparison of standardized uptake values with volume of distribution for quantitation of [11C]PBR28 brain uptake. Nucl Med Biol. 2015;42:305–8. doi:10.1016/j.nucmedbio.2014.11.003.